NO20012732D0 - Vitronectin reseptor antagonist - Google Patents

Vitronectin reseptor antagonist

Info

Publication number
NO20012732D0
NO20012732D0 NO20012732A NO20012732A NO20012732D0 NO 20012732 D0 NO20012732 D0 NO 20012732D0 NO 20012732 A NO20012732 A NO 20012732A NO 20012732 A NO20012732 A NO 20012732A NO 20012732 D0 NO20012732 D0 NO 20012732D0
Authority
NO
Norway
Prior art keywords
receptor antagonist
vitronectin receptor
vitronectin
antagonist
receptor
Prior art date
Application number
NO20012732A
Other languages
English (en)
Other versions
NO20012732L (no
NO318895B1 (no
Inventor
William H Miller
Peter J Manley
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20012732D0 publication Critical patent/NO20012732D0/no
Publication of NO20012732L publication Critical patent/NO20012732L/no
Publication of NO318895B1 publication Critical patent/NO318895B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
NO20012732A 1998-12-04 2001-06-01 Vitronektinreseptor-antagonist NO318895B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11090398P 1998-12-04 1998-12-04
PCT/US1999/028662 WO2000033838A1 (en) 1998-12-04 1999-12-03 Vitronectin receptor antagonist

Publications (3)

Publication Number Publication Date
NO20012732D0 true NO20012732D0 (no) 2001-06-01
NO20012732L NO20012732L (no) 2001-08-01
NO318895B1 NO318895B1 (no) 2005-05-18

Family

ID=22335565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012732A NO318895B1 (no) 1998-12-04 2001-06-01 Vitronektinreseptor-antagonist

Country Status (39)

Country Link
US (1) US6495560B1 (no)
EP (1) EP1146874B1 (no)
JP (1) JP4481504B2 (no)
KR (1) KR100620485B1 (no)
CN (1) CN1147300C (no)
AP (1) AP1534A (no)
AR (1) AR035006A1 (no)
AT (1) ATE277043T1 (no)
AU (1) AU754408B2 (no)
BG (1) BG65118B1 (no)
BR (1) BR9915879A (no)
CA (1) CA2353415A1 (no)
CO (1) CO5150166A1 (no)
CZ (1) CZ20011963A3 (no)
DE (1) DE69920518T2 (no)
DK (1) DK1146874T3 (no)
DZ (1) DZ2954A1 (no)
EA (1) EA003254B1 (no)
EG (1) EG24025A (no)
ES (1) ES2229798T3 (no)
HK (1) HK1042037B (no)
HU (1) HUP0104804A3 (no)
ID (1) ID28811A (no)
IL (2) IL143390A0 (no)
MA (1) MA25265A1 (no)
NO (1) NO318895B1 (no)
NZ (1) NZ511876A (no)
OA (1) OA11724A (no)
PE (1) PE20001563A1 (no)
PL (1) PL195973B1 (no)
PT (1) PT1146874E (no)
SI (1) SI1146874T1 (no)
SK (1) SK7452001A3 (no)
TR (1) TR200101654T2 (no)
TW (1) TW482673B (no)
UA (1) UA71586C2 (no)
UY (1) UY25824A1 (no)
WO (1) WO2000033838A1 (no)
ZA (1) ZA200104398B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001269821A1 (en) 2000-06-15 2001-12-24 Barbara Chen Cycloalkyl alkanoic acids as integrin receptor antagonists
US6943156B2 (en) * 2000-10-24 2005-09-13 Merck & Co., Inc Dibenzoxazepine αv integrin receptor antagonist
CA2436130A1 (en) 2001-01-29 2002-08-08 3-Dimensional Pharmaceuticals, Inc. Substituted indoles and their use as integrin antagonists
US6872730B2 (en) * 2001-04-27 2005-03-29 3-Dimensional Pharmaceuticals, Inc. Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
CA2510084A1 (en) 2002-12-20 2004-07-15 Pharmacia Corporation Thiazole compounds as integrin receptor antagonists derivatives
GB0319069D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Therapeutically useful compounds
WO2006069079A2 (en) * 2004-12-21 2006-06-29 Smithkline Beecham Corporation Methods and formulations
EA022046B1 (ru) 2010-07-14 2015-10-30 Новартис Аг Гетероциклические соединения, агонисты рецептора ip
TW201335160A (zh) 2012-01-13 2013-09-01 Novartis Ag Ｉｐ受體激動劑之雜環化合物
ES2637719T3 (es) 2013-02-13 2017-10-16 Novartis Ag Compuestos heterocíclicos agonistas del receptor IP
EP4249471A3 (en) 2013-09-24 2023-10-18 FUJIFILM Corporation Pharmaceutical composition of a nitrogen-containing compound or salt thereof, or metal complex thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687154B1 (fr) 1992-02-07 1995-05-12 Rhone Poulenc Rorer Sa Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
SI0910563T1 (en) * 1995-06-29 2003-10-31 Smithkline Beecham Corporation Integrin receptor antagonists
WO1998013278A1 (de) * 1996-09-27 1998-04-02 Merkler, H. Tank für flüssigkeiten, insbesondere für chemisch aggressive flüssigkeiten
EP0946180A4 (en) 1996-10-07 2003-07-23 Smithkline Beecham Corp METHODS FOR STIMULATING BONE FORMATION
UY24949A1 (es) 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
AP1534A (en) 2006-01-09
PT1146874E (pt) 2005-02-28
ID28811A (id) 2001-07-05
KR100620485B1 (ko) 2006-09-13
BR9915879A (pt) 2002-02-13
ATE277043T1 (de) 2004-10-15
KR20010080669A (ko) 2001-08-22
BG65118B1 (bg) 2007-03-30
AR035006A1 (es) 2004-04-14
AU1750200A (en) 2000-06-26
EA200100618A1 (ru) 2001-12-24
CN1147300C (zh) 2004-04-28
NO20012732L (no) 2001-08-01
EG24025A (en) 2008-03-26
NZ511876A (en) 2004-02-27
SK7452001A3 (en) 2001-12-03
ES2229798T3 (es) 2005-04-16
DE69920518D1 (de) 2004-10-28
CA2353415A1 (en) 2000-06-15
HUP0104804A2 (hu) 2002-05-29
DK1146874T3 (da) 2005-01-31
JP4481504B2 (ja) 2010-06-16
DE69920518T2 (de) 2005-09-22
SI1146874T1 (en) 2005-04-30
EP1146874A1 (en) 2001-10-24
MA25265A1 (fr) 2001-10-01
HUP0104804A3 (en) 2002-12-28
NO318895B1 (no) 2005-05-18
UA71586C2 (en) 2004-12-15
JP2003523931A (ja) 2003-08-12
PE20001563A1 (es) 2001-02-09
EP1146874B1 (en) 2004-09-22
TW482673B (en) 2002-04-11
EA003254B1 (ru) 2003-02-27
DZ2954A1 (fr) 2004-06-20
HK1042037B (zh) 2005-07-29
ZA200104398B (en) 2002-05-29
CO5150166A1 (es) 2002-04-29
IL143390A (en) 2006-07-05
AU754408B2 (en) 2002-11-14
PL195973B1 (pl) 2007-11-30
OA11724A (en) 2005-01-26
TR200101654T2 (tr) 2002-03-21
CN1334730A (zh) 2002-02-06
PL348702A1 (en) 2002-06-03
EP1146874A4 (en) 2002-06-05
IL143390A0 (en) 2002-04-21
UY25824A1 (es) 2001-07-31
US6495560B1 (en) 2002-12-17
BG105651A (en) 2002-02-28
WO2000033838A1 (en) 2000-06-15
HK1042037A1 (en) 2002-08-02
CZ20011963A3 (cs) 2001-11-14

Similar Documents

Publication Publication Date Title
BR9712248A (pt) Antagonista receptores de vitronectina
IS5706A (is) Adenosín A3 viðtakastillar
NO993350D0 (no) Vitronectin-reseptor-antagonister
DE69921351D1 (de) 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
NO20004503L (no) Vitronectin-reseptor-antagonister
NO20001514D0 (no) Vitronectin-reseptor-antagonist
NO20001515D0 (no) Vitronektin reseptor-antagonist
NO20001407D0 (no) Vitronectin-reseptor-antagonister
NO20016053L (no) IL-8 reseptor-antagonister
DE69920518D1 (de) Vitronectin rezeptor antagonist
NO20016052L (no) IL-8-reseptor-antagonister
ATE352299T1 (de) Il-8 rezeptorantagonist
NO20021113D0 (no) Vitronectin-reseptor-antagonister
NO20015774D0 (no) IL-8 reseptorantagonister
NO20010620D0 (no) Vitronektinreseptor-antagonister
NO20010353L (no) IL-8 reseptor-antagonist
DK1218005T3 (da) Vitronectinreptorantagonister
NO20016102D0 (no) IL-8 reseptorantagonister
NO20016065D0 (no) IL-8-reseptor-antagonister
DE69830671D1 (de) Integrin-rezeptor-antagonisten
SE0003996D0 (sv) Receptorantagonister

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees